Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pola-R-miniCHP in Elderly Frail Patients With DLBCL
NCT07908888Phase 4Recruiting
- Sponsor
- The First Hospital of Jilin University
- Start
- Oct 2026
- Primary completion
- Aug 2029
- Countries
- 1
01
Overview
A Phase 4 trial of polatuzumab vedotin in diffuse large B-cell lymphoma (DLBCL), sponsored by The First Hospital of Jilin University. Started Oct 2026; status: recruiting.
02
Drugs
polatuzumab vedotin
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT07908888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07908888.